A Single Center Pilot Study on the Use of a Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population

Go Back to All Clinical Trials

A Single Center Pilot Study on the Use of a Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population

Brief description of study

This study aims to gather initial data on the potential effectiveness of a transcutaneous auricular vagal nerve stimulation device in patients diagnosed with chronic kidney disease. The study participants will receive a 15-minute session of transcutaneous auricular vagal nerve stimulation at one of two specified doses, assigned alternatively. Prior to and after the stimulation, vital signs, heart rate variability, and autonomic function will be monitored. Our primary aims are to investigate the feasibility of the protocol and generate preliminary signals of efficacy and tolerability for two different doses of vagal nerve stimulation. The pilot estimates will be used to design a larger scale study that may lead to potentially targeted interventions to reduce CV mortality in the CKD population.

Clinical Study Identifier: s23-00778

ClinicalTrials.gov Identifier: NCT05981183

Principal Investigator: David Michael Charytan.

Other Investigator: Qandeel Haq Soomro.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies